480 related articles for article (PubMed ID: 27074098)
1. Recent advances in liposome surface modification for oral drug delivery.
Nguyen TX; Huang L; Gauthier M; Yang G; Wang Q
Nanomedicine (Lond); 2016 May; 11(9):1169-85. PubMed ID: 27074098
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.
Tahara K; Nishio M; Takeuchi H
Drug Dev Ind Pharm; 2018 Apr; 44(4):608-614. PubMed ID: 29166794
[TBL] [Abstract][Full Text] [Related]
3. Potential of Liposomes for Enhancement of Oral Drug Absorption.
Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems.
Hermida LG; Sabés-Xamaní M; Barnadas-Rodríguez R
Soft Matter; 2014 Sep; 10(35):6677-85. PubMed ID: 25060405
[TBL] [Abstract][Full Text] [Related]
5. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
Budai M; Szógyi M
Acta Pharm Hung; 2001; 71(1):114-8. PubMed ID: 11769091
[TBL] [Abstract][Full Text] [Related]
6. Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.
Lai WF; Wong WT; Rogach AL
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43341-43351. PubMed ID: 32877163
[TBL] [Abstract][Full Text] [Related]
7. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.
Aburahma MH
Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191
[TBL] [Abstract][Full Text] [Related]
8. Effect of liposomes on the absorption of water-soluble active pharmaceutical ingredients via oral administration.
Yang Z; Lu A; Wong BC; Chen X; Bian Z; Zhao Z; Huang W; Zhang G; Chen H; Xu M
Curr Pharm Des; 2013; 19(37):6647-54. PubMed ID: 23621538
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of vancomycin by tetraether lipid liposomes.
Uhl P; Pantze S; Storck P; Parmentier J; Witzigmann D; Hofhaus G; Huwyler J; Mier W; Fricker G
Eur J Pharm Sci; 2017 Oct; 108():111-118. PubMed ID: 28716758
[TBL] [Abstract][Full Text] [Related]
10. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting microencapsulation of drugs in liposomes.
Kulkarni SB; Betageri GV; Singh M
J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
[TBL] [Abstract][Full Text] [Related]
12. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
Wong CY; Al-Salami H; Dass CR
Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
[TBL] [Abstract][Full Text] [Related]
13. The potential of liposomes as dental drug delivery systems.
Nguyen S; Hiorth M; Rykke M; Smistad G
Eur J Pharm Biopharm; 2011 Jan; 77(1):75-83. PubMed ID: 20875853
[TBL] [Abstract][Full Text] [Related]
14. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
[TBL] [Abstract][Full Text] [Related]
15. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
Karamanidou T; Bourganis V; Kammona O; Kiparissides C
Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
[TBL] [Abstract][Full Text] [Related]
16. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin.
Huang YB; Tsai MJ; Wu PC; Tsai YH; Wu YH; Fang JY
J Drug Target; 2011 Sep; 19(8):709-18. PubMed ID: 21303222
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Schroeder A; Kost J; Barenholz Y
Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
[TBL] [Abstract][Full Text] [Related]
18. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene.
Peng RM; Lin GR; Ting Y; Hu JY
Biofactors; 2018 Jan; 44(1):5-15. PubMed ID: 29322567
[TBL] [Abstract][Full Text] [Related]
20. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
